Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 3 (2006), Issue 8 (August)

1. Alternative splicing variants of IRF-1 lacking exons 7, 8, and 9 in cervical cancer.
   Biochem Biophys Res Commun, 347(4): 882-8. [Abstract] [Full-text]
2. Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women.
   Am J Clin Pathol, 126(3): 381-8. [Abstract] [Full-text]
3. Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro.
   Cancer Chemother Pharmacol, 58(5): 665-72. [Abstract] [Full-text]
4. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
   Int J Radiat Oncol Biol Phys, 66(1): 83-90. [Abstract] [Full-text]
5. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa.
   Int J Cancer, 119(6): 1389-95. [Abstract] [Full-text]
6. Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
   Biochem Pharmacol, 72(6): 693-700. [Abstract] [Full-text]
7. Description of patients with squamous cell carcinoma in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study.
   Cancer, 108(4): 212-21. [Abstract] [Full-text]
8. Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions.
   Cancer, 107(5): 999-1007. [Abstract] [Full-text]
9. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
   Cancer, 107(5): 908-15. [Abstract] [Full-text]
10. Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
    Int J Cancer, 119(8): 1908-14. [Abstract] [Full-text]
11. Reduced incidence of cervical cancer in mothers of sons with allergic rhinoconjunctivitis, asthma or eczema.
    Int J Cancer, 119(8): 1994-8. [Abstract] [Full-text]
12. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Oncogene, 25(39): 5436-45. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.